Oruka Therapeutics, Inc. (ORKA)

NASDAQ: ORKA · Real-Time Price · USD

10.95

-0.90 (-7.59%)

At close: May 30, 2025, 4:00 PM

10.96

+0.01 (0.09%)

After-hours: May 30, 2025, 4:20 PM EDT

Oruka Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024
Net Income	-105.26	-91.34
Depreciation & Amortization	0.05	0.03
Loss (Gain) From Sale of Investments	-4.25	-2.45
Stock-Based Compensation	21.07	16.28
Other Operating Activities	1.8	1.74
Change in Accounts Payable	-0.61	10.35
Change in Other Net Operating Assets	3.4	2.3
Operating Cash Flow	-83.8	-63.09
Capital Expenditures	-0.22	-0.21
Investment in Securities	-317.05	-359.93
Investing Cash Flow	-317.27	-360.14
Total Debt Issued	2.27	27.25
Net Debt Issued (Repaid)	2.27	27.25
Issuance of Common Stock	454.57	454.57
Other Financing Activities	5.39	5.39
Financing Cash Flow	462.5	490.41
Net Cash Flow	61.43	67.17
Free Cash Flow	-84.02	-63.3
Free Cash Flow Per Share	-3.18	-3.77

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q